Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29864958 | 0.91 | ALDH1A1 (0.47) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL22650215 | 0.85 | ALDH1A1 (0.49) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL8982598 | 0.85 | ALDH1A1 (0.43) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL8496774 | 0.83 | ALDH1A1 (0.42) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| Ethylene Glycol SCHEMBL3799386 | 0.83 | ALDH1A1 (0.40) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL869592 | 0.82 | ALDH1A1 (0.53) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL8142983 | 0.82 | ALDH1A1 (0.65) | ALDH1A1KDM4EGAAHSD17B10CYP1A2 | |
| SCHEMBL29429255 | 0.82 | ALDH1A1 (0.53) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL8683108 | 0.82 | ALDH1A1 (0.47) | CYP3A4SMN1; SMN2ALDH1A1KDM4EGAA | |
| SCHEMBL1593695 | 0.81 | ALDH1A1 (0.47) | CYP3A4ALDH1A1KDM4EGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140206595-A1 | CLEANING MIXTURE FOR THE REMOVAL OR AVOIDANCE OF INSECT DEPOSITS ON SURFACES | EADS DEUTSCHLAND GMBH (DE) | 2014-07-24 | — | — | US | claimed |
| WO-2011104027-A1 | PROCESS FOR PARALLEL ISOLATION AND/OR PURIFICATION OF RNA AND DNA | QIAGEN GMBH (DE) | 2011-09-01 | — | — | WO | claimed |
| US-4143080-A | WATER SOLUBLE IODIDE, REDOX CATALYST, STABILIZER IN SPECIFIC CONCENTRATIONS FOR PHOTOMETRIC DETERMINATIONS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-03-06 | — | — | US | claimed |
| US-20230172846-A1 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V. (MX) | 2023-06-08 | — | — | US | disclosed |
| EP-4084781-A1 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | TF Tech Ventures (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-115297851-A | Orosol film and method of making and using same | TF科技企业 | 2022-11-04 | — | — | CN | disclosed |
| US-20140206595-A1 | CLEANING MIXTURE FOR THE REMOVAL OR AVOIDANCE OF INSECT DEPOSITS ON SURFACES | EADS DEUTSCHLAND GMBH (DE) | 2014-07-24 | — | — | US | disclosed |
| WO-2011104027-A1 | PROCESS FOR PARALLEL ISOLATION AND/OR PURIFICATION OF RNA AND DNA | QIAGEN GMBH (DE) | 2011-09-01 | — | — | WO | disclosed |
| US-4143080-A | WATER SOLUBLE IODIDE, REDOX CATALYST, STABILIZER IN SPECIFIC CONCENTRATIONS FOR PHOTOMETRIC DETERMINATIONS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-03-06 | — | — | US | disclosed |
| US-4062730-A | PSEUDOMONAS FLUORESCENS | Malkki, Yrjo (SF) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172846-A1 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | DSTN, FDFT1, DDHD2 | CYP3A4 328/4885SMN1; SMN2 3783/4885ALDH1A1 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.